Administration of perflutren contrast agents during transthoracic echocardiography is not associated with a significant increase in acute mortality risk

Ythan H. Goldberg, Paul Ginelli, Robert Siegel, Robert J. Ostfeld, Michael Schaefer, Daniel M. Spevack

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Administration of perflutren contrast agents during transthoracic echocardiography is not associated with a significant increase in acute mortality risk'. Together they form a unique fingerprint.

Medicine & Life Sciences